Shroom News,Spotlight Stock Nova Mentis Orphan Drug Approved by the United States FDA By Dennis Mutua November 03, 2021 Biotechnology company specializing in investigating the anti-inflammatory effects of psilocybin in less researched metabolic conditions Nova Mentis Life Science Corp. (CSE: NOVA) (OTCQB: NMLSF) announced that the United States Foo...
Psychedelic Stocks,Shroom News David Ascott Appointed New CFO at Red Light Holland By Dennis Mutua November 02, 2021 Ontario based psychedelics company specializing on production and production of magical truffles Red Light Holland Corp. (CSE: TRIP) (OTCMKTS: TRUFF) announced having appointed David Ascott as the new chief financial officer of th...
Psychedelic Stocks,Shroom News HAVN Life Sciences’ Board Member Rick Brar Leaves the Company By Dennis Mutua October 26, 2021 Biotechnology company focusing on standardizing extraction of psychedelics to develop natural health products for treatment of mental health conditions HAVN Life Sciences Inc. (CSE: HAVN) (OTCMKTS: HAVLF) announced that Rick Brar,...
Featured,Shroom News Miami Based Emotional Intelligence Ventures Raises $20 Million for Mental Wellness By Dennis Mutua October 22, 2021 Miami based company empowering mental wellness through psychoactive compounds and technology, Emotional Intelligence Ventures announced having raised $20 million in a Regulation A offering which it will be using to advance mental ...
Psychedelic Stocks,Shroom News Numinus Progresses Phase 1 Clinical Trial on Proprietary Psilocybin Product By Dennis Mutua October 21, 2021 Health care company focused on merging latest psychedelics medicine with best evidenced-based care and a holistic integrated approach to treating mental conditions Numinus Wellness Inc. (CVE: NUMI) announced having finished the st...
Featured,Shroom News COMPASS Pathways Secures UPTSO Patent for Crystalline Psilocybin By Dennis Mutua October 20, 2021 Mental healthcare company focusing on speeding patient access to evidence-based innovation in mental health COMPASS Pathways Plc. (NASDAQ: CMPS) announced having secured patent approval from United States Patent and Trademark Offi...
Psychedelic Stocks,Shroom News Russell Peters to Have His First Psychedelic Experience With Red Light Holland By Dennis Mutua October 19, 2021 Psychedelic focused company specializing on production and sale of medical grade truffles Red Light Holland (CSE: TRIP) (OTC PINK: TRUFF) announced that its chief creative officer, Russell Peters, will be taking part in his first ...
Psychedelic Stocks,Shroom News MindMed Joins Clinical Trials Transformation Initiative By Dennis Mutua October 15, 2021 Psychedelic medicine biotech company developing psychedelic-inspired medicine and therapies to treat addiction and mental conditions MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) announced having joined Clinical Trials Transformation In...
